You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TNGX Sale Disclosure
Crystal Adam · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$575.96K
Crystal Adam President, R&d
TNGX
Tango Therapeutics
TNGX
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
TNGX daily price context
Close on/before transaction
$28.73
Jul 1, 2026
First close after public filing
$29.94
Jul 6, 2026
30-day return after filing
-9.12%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 19,629 shares @ $29.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-295124
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$939.31K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tango Therapeutics, Inc. TNGX | Exercise | Jul 1, 2026 | $140.4K |
| Tango Therapeutics, Inc. TNGX Current | Sale | Jul 1, 2026 | $575.96K |
| Tango Therapeutics, Inc. TNGX | Sale | Jul 1, 2026 | $222.95K |
| Tango Therapeutics, Inc. TNGX | Exercise | Jul 1, 2026 | $0 |